Pargyline

This classification denotes a monoamine oxidase inhibitor and antihypertensive agent with the molecular formula C11H13N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9MV14S8G3E, chemically known as 2-propynylamine, n-benzyl-n-methyl-, hydrochloride but generally known as pargyline, which bears US NIH Compound Identifier 4688. European Medicines Agency schedules Pargyline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09626MIG. The term PARGYLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules pargyline in its Anatomical Therapeutic Chemical (ATC) Classification. PARGYLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pargyline under HS 29214980 and SITC 51454. As of Q4 2014, PARGYLINE remains the US FDA Preferred Term for this commodity. Pargyline bears US NLM identifiers UMLS ID C0030557 and NCI Concept Code C66322. SMILES: CN(CC#C)CC1=CC=CC=C1.